🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro savings card update — July 2024 Page 5

Mounjaro savings card update — July 2024

tammy_FL Wed, Feb 7, 2024 at 5:59 PM 60 replies 3,510 viewsPage 5 of 12
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Feb 9, 2024 at 8:15 AM#21
stefan_berlin said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

31 4VendorMark, COA_Karl, MikeFit_NJ and 28 others
Reply Quote Save Share Report
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Feb 9, 2024 at 2:40 PM#22
stefan_berlin said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

That holds where the measurement is reliable. Where it is noisy — and a lot of what gets tracked here is noisy — the same reasoning produces confident nonsense.

Last edited: Feb 9, 2024 at 8:40 PM
32 5pete_RVA, CarlaRPh_TPA, steph_laguna and 29 others
Reply Quote Save Share Report
MounjBrad
Member
278
890
Oct 2024
Kentucky
Feb 9, 2024 at 9:05 PM#23
stefan_berlin said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

This answered a question I did not know how to ask. I will report back once I have actually tried it.

33 6nick_SD_fit, ben_calgary, patPC_UT and 30 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Feb 10, 2024 at 3:30 AM#24

Clinical perspective, offered as context rather than as advice. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

34 7pete_nash, hank_denver, carlos_SATX and 31 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Feb 10, 2024 at 9:55 AM#25
NurseKim_ATL said:
It is worth asking what the claim would look like if it were false.

This matches mine closely enough to be worth saying so out loud.

35 8SaraMom3, Dr.MetabolicMD, RetaRick_CA and 32 others
Reply Quote Save Share Report
13456712

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register